TotalMarketCap

DiaMedica Therapeutics

DMACNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$488.567 M

$9.06 -15.88%

Close of 6 Nov 2026

As of 6 Nov 2026, DiaMedica Therapeutics (DMAC) has a market capitalization of $488.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$32.8M

Loss-making

Shares outstanding

53,925,697

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #188Ovid TherapeuticsOVID$503.9M
  2. #189Capricor TherapeuticsCAPR$499.4M
  3. #190DiaMedica TherapeuticsDMAC$488.6M
  4. #191Indaptus TherapeuticsINDP$483.8M
  5. #192Crescent BiopharmaCBIO$482.1M

What if DiaMedica Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$523,625.57

Per share 57,795× higher

Bitcoin $1.53T

$28,332.47

Per share 3,127× higher

Apple $5.02T

$93,012.85

Per share 10,266× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for DiaMedica Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.